Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis.

Literature DB >> 21193428

Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis.

Animesh Pardanani, Ayalew Tefferi.

Abstract

Entities: Disease

Mesh：

Year: 2011 PMID： 21193428 PMCID： PMC3012757 DOI： 10.3324/haematol.2010.035519

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

25 in total

Review 1. Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisal.

Authors: A M Vannucchi; E Antonioli; P Guglielmelli; A Pardanani; A Tefferi
Journal: Leukemia Date: 2008-05-22 Impact factor: 11.528

2. Neither serum ferritin nor the number of red blood cell transfusions affect overall survival in refractory anemia with ringed sideroblasts.

Authors: Cheng E Chee; David P Steensma; Wenting Wu; Curtis A Hanson; Ayalew Tefferi
Journal: Am J Hematol Date: 2008-08 Impact factor: 10.047

Review 3. Pathogenesis of myelofibrosis with myeloid metaplasia.

Authors: Ayalew Tefferi
Journal: J Clin Oncol Date: 2005-11-20 Impact factor: 44.544

4. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.

Authors: Luca Malcovati; Matteo Giovanni Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Marina Boni; Erica Travaglino; Francesco Passamonti; Luca Arcaini; Margherita Maffioli; Paolo Bernasconi; Mario Lazzarino; Mario Cazzola
Journal: J Clin Oncol Date: 2005-09-26 Impact factor: 44.544

5. International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors: P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal: Blood Date: 1997-03-15 Impact factor: 22.113

6. Anaemia characterises patients with myelofibrosis harbouring Mpl mutation.

Authors: Paola Guglielmelli; Alessandro Pancrazzi; Gaetano Bergamaschi; Vittorio Rosti; Laura Villani; Elisabetta Antonioli; Alberto Bosi; Giovanni Barosi; Alessandro M Vannucchi
Journal: Br J Haematol Date: 2007-05 Impact factor: 6.998

7. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

Authors: Francisco Cervantes; Brigitte Dupriez; Arturo Pereira; Francesco Passamonti; John T Reilly; Enrica Morra; Alessandro M Vannucchi; Ruben A Mesa; Jean-Loup Demory; Giovanni Barosi; Elisa Rumi; Ayalew Tefferi
Journal: Blood Date: 2008-11-06 Impact factor: 22.113

8. A prognostic score for patients with lower risk myelodysplastic syndrome.

Authors: G Garcia-Manero; J Shan; S Faderl; J Cortes; F Ravandi; G Borthakur; W G Wierda; S Pierce; E Estey; J Liu; X Huang; H Kantarjian
Journal: Leukemia Date: 2007-12-13 Impact factor: 11.528

9. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System.

Authors: Hagop Kantarjian; Susan O'Brien; Farhad Ravandi; Jorge Cortes; Jianqin Shan; John M Bennett; Alan List; Pierre Fenaux; Guillermo Sanz; Jean-Pierre Issa; Emil J Freireich; Guillermo Garcia-Manero
Journal: Cancer Date: 2008-09-15 Impact factor: 6.860

10. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.

Authors: Luca Malcovati; Ulrich Germing; Andrea Kuendgen; Matteo G Della Porta; Cristiana Pascutto; Rosangela Invernizzi; Aristoteles Giagounidis; Barbara Hildebrandt; Paolo Bernasconi; Sabine Knipp; Corinna Strupp; Mario Lazzarino; Carlo Aul; Mario Cazzola
Journal: J Clin Oncol Date: 2007-08-10 Impact factor: 44.544

3 in total